// Get Polylux from the official package repository
#import "@preview/polylux:0.3.1": *
#import "@preview/fletcher:0.5.1" as fletcher: diagram, node, edge
#import themes.simple: *
#import fletcher.shapes: diamond


// Make the paper dimensions fit for a presentation and the text larger
#set page(paper: "presentation-16-9")
#set footnote.entry(clearance: 0.1em, gap: 0.2em)
#show heading:set align(start + top)
#show heading: set text(size: 28pt)
#set align(horizon)

#let lb = linebreak(justify: false)

#set list(marker: ([â€¢], [â—¦], [ğŸ—¸]))
#let list-counter = counter("list")

#show list: set text(14pt)
#show list: it => {
  list-counter.step()

  context {
    set text(24pt) if list-counter.get().first() == 1
    set text(20pt) if list-counter.get().first() == 2
    set text(16pt) if list-counter.get().first() >= 3
    it
  }
  list-counter.update(i => i - 1)
}

// for main text
#set text(
    lang: "ja",  // è‹±èªã—ã‹ä½¿ã‚ãªã„æ–‡æ›¸ã§ã¯"en"ã¨ã™ã‚‹ï¼ˆã‚‚ã—ãã¯æŒ‡å®šã—ãªã„ï¼‰
    font: ("Calibri", "Noto Serif CJK JP"),  
    // font: (æ—¥æœ¬èªæ–‡å­—ã‚’å«ã¾ãªã„ãƒ•ã‚©ãƒ³ãƒˆ, æ—¥æœ¬èªæ–‡å­—ã‚’å«ã‚€ãƒ•ã‚©ãƒ³ãƒˆ),  ã¨ãªã£ã¦ã„ã‚‹
)


// Use #polylux-slide to create a slide and style it using your favourite Typst functions
#polylux-slide[

#align(horizon + center)[
  #text(size: 36pt, weight: "bold")[
    Creutzfeldt-Jakobç—…(CJD)ã®è¨ºç™‚ã«ã¤ã„ã¦
  ]
  
  #text(size: 24pt)[
    Nozomi Niimi #lb
    2024/12/4
  ]

]
]



#polylux-slide[
  == ç—‡ä¾‹
  
  - 78æ­³å¥³æ€§
  - 1ãƒ¶æœˆå‰ã‹ã‚‰ã®ä½“å‹•å›°é›£
  - å…¥é™¢å¾Œæ€¥æ¿€ã«èªçŸ¥æ©Ÿèƒ½ä½ä¸‹ãŒé€²è¡Œ
  - å½“åˆã¯è„³ç‚ãªã©ç–‘ã„ã€CSFãŠã‚ˆã³MRIæ¤œæŸ»
    - MRIã«ã¦CJDç–‘ã„

]

#polylux-slide[
  == CJDã¨ã¯

  - Creutzfeldt-Jakobç—…
  - Prionç—…ã®ä¸€ã¤
  - æœ‰ç—…ç‡ã¯1ï½2/100ä¸‡äººã¨ã•ã‚Œã‚‹å¸Œå°‘ç–¾æ‚£
    - ç‰¹ç™ºæ€§å¤šä¸­å¿ƒæ€§ã‚­ãƒ£ãƒƒã‚¹ãƒ«ãƒãƒ³ç—…ã¨åŒã˜ãã‚‰ã„ã®ç™ºç—‡ç‡
  - å®Ÿã¯ä¼æŸ“ç—…ã¨ã—ã¦5é¡æ„ŸæŸ“ç—‡ã«æŒ‡å®šã•ã‚Œã¦ã„ã‚‹

]

#polylux-slide[
  == CJDã®åˆ†é¡ã¨ç–«å­¦

  #figure(image("figures/cjd_piechart.jpeg", height: 70%))
  
  - æ—¥æœ¬ã§ã¯3/4ä»¥ä¸ŠãŒå­¤ç™ºæ€§

]


#polylux-slide[
  == CJDã®è¨ºæ–­ã®é“é †

  #figure(image("figures/cjd_diagnosis_flow.jpeg", height: 55%))
  #align(right)[
   #text(size: 12pt)[
    http://prion.umin.jp/guideline/pdf/guideline_temp_2023.pdf]]

  - æ€¥é€Ÿé€²è¡Œæ€§(2å¹´ä»¥å†…ã€é€šå¸¸1ãƒ¶æœˆï½1å¹´)èªçŸ¥ç—‡ã§ç–‘ã† 
]

#polylux-slide[
  == CJDã®ç—‡çŠ¶ã«ã¤ã„ã¦

  #side-by-side(gutter: 0mm, columns: (1fr, 1fr))[
    #figure(image("figures/cjd_symptoms.jpeg", height: 50%))
  ][
    #figure(image("figures/cjd_symptoms_type.jpeg", height: 50%))
  ]
  - å…¸å‹ä¾‹ã€éå…¸å‹ä¾‹ãŒã‚ã‚‹ãŒã€æœ€å¾Œã¯ç„¡è¨€ãƒ»ç„¡å‹•ã«ãªã‚‹  
  - ãƒŸã‚ªã‚¯ãƒ­ãƒ¼ãƒŒã‚¹ã€é‹å‹•å¤±èª¿ã€è¦–è§’ç•°å¸¸ã€éŒä½“(å¤–)è·¯ç—‡çŠ¶ãªã© #lb å¤šå½©ãªç¥çµŒç—‡çŠ¶ã‚’å‘ˆã™ã‚‹  #h(1fr) #text(size: 12pt)[
    Pract Neurol. 2017;17(2):113-121.
    ]
 
]


#polylux-slide[
  == CJDã§å¿…è¦ãªå•è¨º

  - ãƒ—ãƒªã‚ªãƒ³ç—…ã‚µãƒ¼ãƒ™ã‚¤ãƒ©ãƒ³ã‚¹ã®é …ç›®ã‚ˆã‚Š
    - é£Ÿäº‹ã®å—œå¥½
    - è©³ç´°ãªå®¶æ—æ­´  
      - ã—ã£ã‹ã‚Šã¨ç¥–çˆ¶æ¯ã¾ã§èã„ã¦ã„ã 
    - æµ·å¤–æ¸¡èˆªæ­´ã¨ãã®æœŸé–“
      - EUã¨ã‚¤ã‚®ãƒªã‚¹(1980-1996å¹´) 
      
  #align(right)[
   #text(size: 12pt)[
    https://www.mhlw.go.jp/content/11127000/001168596.
    pdf]]
    
    - æ‰‹è¡“æ­´
      - è¼¸è¡€æ­´ã€é ­è“‹å†…æ‰‹è¡“ã€*ç¡¬è†œç§»æ¤æ­´*ã€æ­¯ç§‘æ²»ç™‚ãªã©
  

]
  

#polylux-slide[
  == CJDã®è¨ºæ–­


#figure(image("figures/cjd_diagnosis.jpeg", height: 50%))
  - æœ¬æ¥ã¯è„³ç”Ÿæ¤œã«ã‚ˆã‚‹çµ„ç¹”è¨ºãŒå¿…è¦
    - ã—ã‹ã—ã€ãã‚Œã ã¨äº¡ããªã‚‹ã¾ã§è¨ºæ–­ãŒä¸å¯èƒ½
  - æœ€è¿‘ã ã¨ã€ä»¥ä¸‹ã®æ¤œæŸ»ãŒçµ„ã¿åˆã‚ã›ã¦è¡Œã‚ã‚Œã‚‹
    - é ­éƒ¨MRI + è„³æ³¢ + é«„æ¶²æ¤œæŸ»
  
]


#slide[

 #side-by-side(gutter: 0mm, columns: (1.6fr, 1fr))[

  == CJDã®è¨ºæ–­ï½MRI

  - å˜ç´”MRIã§è©•ä¾¡
    - é€ å½±å‰¤MRIã§ä»–ã®ç–¾æ‚£é™¤å¤–ã™ã‚‹ã“ã¨ã‚‚ã‚ã‚‹
  - DWIã§å¤§è„³çš®è³ªã®é«˜ä¿¡å· #lb (Cortical ribboning)ã‚„ç·šæ¡ä½“ã®é«˜ä¿¡å·
    - æ„Ÿåº¦83-94%, ç‰¹ç•°åº¦72-95%

][
  #figure(image("figures/cjd_mri.jpeg", height: 60%))


]

#align(right)[
   #text(size: 12pt)[
    
  Brian S Appleby, MD, Mark L Cohen, MD. Creutzfeldt-jakob disease. In: UpToDate, Connor RF (Ed), Wolters Kluwer. Accessed November 24th, 2024. https://www.uptodate.com/contents/creutzfeldt-jakob-disease?source=mostViewed_widget
    ]]
]


#polylux-slide[
  == CJDã®è¨ºæ–­ï½è„³æ³¢

  #figure(image("figures/cjd_eeg.jpeg", height: 40%))
  - 1-2Hzã®å®šæœŸçš„ãªæ£˜æ³¢(2ç›¸ã‚„3ç›¸)ã®è¤‡åˆæ³¢ãŒsCJDã‚’ç¤ºå”†ã™ã‚‹
    - æ„Ÿåº¦67%, ç‰¹ç•°åº¦86%
  - è„³ç‚ã‚„ä»£è¬ã€ä¸­æ¯’ç–¾æ‚£ãªã©ã‚’é™¤å¤–ã™ã‚‹ã®ã«ã‚‚æœ‰ç”¨
  #align(right)[
   #text(size: 12pt)[
    DynaMed. Creutzfeldt-Jakob Disease. EBSCO Information Services. Accessed 2024å¹´11æœˆ26æ—¥. https://www.dynamed.com/condition/creutzfeldt-jakob-disease
    ]
  ] 
  
]


#polylux-slide[
  == CJDã®è¨ºæ–­ï½é«„æ¶²æ¤œæŸ»


  #figure(image("figures/cjd_csf.jpeg", height: 45%))
  - é™¤å¤–è¨ºæ–­ã«å¿…é ˆ
  - 14-3-3è›‹ç™½ãŒæœ‰åã ãŒä»Šã¯ç›´æ¥çš„ã«ç•°å¸¸ãƒ—ãƒªã‚ªãƒ³è›‹ç™½ã‚’æ¤œå‡ºå‡ºæ¥ã‚‹ã€RT-QuICãŒä¸»æµ
  #align(right)[
   #text(size: 12pt)[
      è‡¨åºŠç¥çµŒ 2013;53:1252-1254
    ]
  ] 
      
]

#polylux-slide[
  == é«„æ¶²æ¤œæŸ»ã¯å±é™ºã˜ã‚ƒãªã„ï¼Ÿ

  - è„³è„Šé«„æ¶²ã¯ä½æ„ŸæŸ“æ€§ã ãŒã€è…°æ¤ç©¿åˆºã®æ™‚ã«ã¯ã¡ã‚ƒã‚“ã¨ #lb ãƒ•ã‚§ã‚¤ã‚¹ãƒã‚¹ã‚¯ã‚‚ã¤ã‘ã‚‹
  - ç–‘ã„ã ã‘ã§ã€æ¤œæŸ»ã‚’å·®ã—æ§ãˆã¾ã§ã¯ä¸è¦ã ãŒã€ #lb maximal precautionã§æœ€ä½é™ã®å›æ•°ã«ã™ã‚‹  
  
#align(right)[
   #text(size: 12pt)[
    http://prion.umin.jp/guideline/cjd_2020.pdf
    ]
  ] 
]


#slide[
  
  #side-by-side(gutter: 0mm, columns: (1fr, 1fr))[
  
  == CJDã®è¨ºæ–­ï½é«„æ¶²æ¤œæŸ» 2

  - é•·å´ç—…é™¢ã«æ¤œä½“ã‚’é€ã‚‹
  - ã‚µãƒ¼ãƒ™ã‚¤ãƒ©ãƒ³ã‚¹ã®è³ªå•ç¥¨ã‚„ #lb åŒæ„ã‚’å®¶æ—ã‹ã‚‰å¾—ã‚‹
  - ã‚„ã‚Šæ–¹ãŒé›£ã—ã„

  ][
    #figure(image("figures/nagasaki_hp.jpeg", height: 80%))
  ]

]

#polylux-slide[
  == CJDã®è¨ºæ–­ï½é«„æ¶²æ¤œæŸ» 3

  #text(size: 24pt)[

  + ãƒ¡ãƒ¼ãƒ«ã‚’é•·å´å¤§å­¦ã«é€ã£ã¦ä¾é ¼ã™ã‚‹
  + æ¤œæŸ»ç§‘ã®å¤–æ³¨ã«ç›¸è«‡ã—ã¦ç‰¹æ®Šãªå®¹å™¨ã‚’ã‚‚ã‚‰ã†
  + -20â„ƒã®ä¿å­˜æ¤œä½“ã€‚3Fã®å¥¥ã§ç™ºæ³¡ã‚¹ãƒãƒ­ãƒ¼ãƒ«ã®å®¹å™¨ã¨é‡‘æ§Œã‚’ã‚‚ã‚‰ã£ã¦ã€ #lb ãƒ‰ãƒ©ã‚¤ã‚¢ã‚¤ã‚¹ã‚’è‡ªåˆ†ã§ç ´ç •ã—ã¦è©°ã‚è¾¼ã‚€
  + æœˆæ›œæ—¥ï½æ°´æ›œæ—¥ã«é«„æ¶²ã¨è¡€æ¼¿ã‚’ä¸€ç·’ã«é€ã‚‹

  ]

  - çµæœã¯æ•°ãƒ¶æœˆã‹ã‹ã‚‹
  - ç¥çµŒå†…ç§‘ã«ç›¸è«‡ã™ã‚‹ã¨è‰¯ã„

]


#polylux-slide[
  == è¨ºæ–­ã—ãŸã‚‰ãƒ»ãƒ»ãƒ»ãƒ»ãƒ»ãƒ»

  - 5é¡æ„ŸæŸ“ç—‡ãªã®ã§ã€ä¿å¥æ‰€ã«å ±å‘Š
  - ã‚µãƒ¼ãƒ™ã‚¤ãƒ©ãƒ³ã‚¹ã§èã„ãŸé …ç›®ã‚’èã
  - ä¸€ç™ºã§OKã«ãªã‚‰ãªã„ã®ã§ä¿å¥æ‰€ã‹ã‚‰é›»è©±ãŒæ¥ã¦ã‚‚æ°—ã«ã—ãªã„

  
]

#polylux-slide[
  == æ³¨æ„ç‚¹ï¼
#set text(size: 14pt)
#table(
  columns: 2,
  [*Commonãªç–¾æ‚£*], [*ç¨€ã ãŒæ²»ç™‚å¯èƒ½ãªç–¾æ‚£*],
  [ATDãªã©ã®ç¥çµŒå¤‰æ€§ç–¾æ‚£], [è‡ªå·±å…ç–«æ€§è„³ç‚],
  [ã›ã‚“å¦„ã¨ä»–ã®èªçŸ¥ç—‡], [ä»£è¬æ€§/å†…åˆ†æ³Œç–¾æ‚£(é›»è§£è³ªç•°å¸¸ã€é«˜NH3æ±ºå‹ã€ä½è¡€ç³–ã€å°¿æ¯’ç—‡)],
  [ã‚¦ã‚£ãƒ«ã‚¹æ€§è„³ç‚], [åŸç™ºæ€§ä¸­æ¢æ€§è¡€ç®¡ç‚],
  [è‚æ€§è„³ç—‡], [ç¥çµŒSarcoidosis], 
  [è„³æ¢—å¡], [Lymphoma], 
  [Wernickeè„³ç—‡], [ç¨€ãªæ„ŸæŸ“ç—‡(PML, æ„ŸæŸ“æ€§è„³ç‚, Lymeç—…, Whippleç—…, ç¥çµŒæ¢…æ¯’)], 
  [ç”²çŠ¶è…ºæ©Ÿèƒ½éšœå®³], [HIVé–¢é€£èªçŸ¥ç—‡, CNS lupus, é‡é‡‘å±ä¸­æ¯’, è–¬ç‰©ä¸­æ¯’, NCSE, ç²¾ç¥ç–¾æ‚£ãªã©]
)

  - CJDã¯ã©ã“ã¾ã§è¡Œã£ã¦ã‚‚é™¤å¤–è¨ºæ–­
  - é‘‘åˆ¥ç–¾æ‚£ã¯è†¨å¤§ã ãŒã€treatableãªç–¾æ‚£ãŒã‚ˆã‚Šé‡è¦
  - CJDé‘‘åˆ¥ã®æ™‚ã«ã¯ä»¥ä¸‹ã®Red flagã‚’æ¢ã™
  
  #align(right)[
   #text(size: 12pt)[
    Pract Neurol. 2017;17(2):113-121.
    ]
  ] 
]

#polylux-slide[
  == CJDã®red flag
  
#align(center)[
  #set text(size: 16pt)
#table(
  columns: 2,
  [*Red flag*], [*é‘‘åˆ¥è¨ºæ–­*],
  [ç™ºç†±], [ä¸­æ¢æ„ŸæŸ“ç—‡, Lymphoma],
  [ç—™æ”£], [ä¸­æ¢æ„ŸæŸ“ç—‡ã€è‡ªå·±å…ç–«æ€§è„³ç‚ã€æ‚ªæ€§è…«ç˜ãªã©],
  [ä½Naè¡€ç—‡], [VGKCæŠ—ä½“é–¢é€£è„³ç‚],
  [é¡”é¢ã®ç•°å¸¸é‹å‹•], [NMDA-Rè„³ç‚ã€ä¸­æ¢Whippleç—…], 
  [CSFã®ç´°èƒæ•°å¢—å¤š], [ä¸­æ¢æ„ŸæŸ“ç—‡, Lymphoma, æ‚ªæ€§è…«ç˜ãªã©], 
  [é€ å½±MRIã§ã®ç•°å¸¸é«˜ä¿¡å·], [ä¸­æ¢æ„ŸæŸ“ç—‡, Lymphoma, æ‚ªæ€§è…«ç˜ãªã©]
)
]
  
  - CJDã‚’ç–‘ã‚ã‚ŒãŸæ‚£è€…ã®ç—…ç†ã§32%ã¯é•ã†ã¨ã„ã†çµæœãŒã‚ã£ãŸ
    - ã•ã‚‰ã«ã€ãã®ã†ã¡#text(size: 24pt, fill: red, weight: "bold")[23%(å…¨ä½“ã®6%)]ã¯treatableã ã£ãŸ
    - å†…è¨³ã¯è‡ªå·±å…ç–« > æ„ŸæŸ“ç—‡ > æ‚ªæ€§è…«ç˜ > ä»£è¬æ€§ç–¾æ‚£
    - æœ€å¤§ã®é‘‘åˆ¥ç–¾æ‚£ã¯#text(fill: red)[*è‡ªå·±å…ç–«æ€§è„³ç‚*] 
#align(right)[
   #text(size: 12pt)[
Ann Neurol. 2011;70(3):437-444.
Continuum. 2016;22(2 Dementia):510-537.

]
  ] 
]


#polylux-slide[
  == è‡ªå·±å…ç–«æ€§è„³ç‚
  #side-by-side(gutter: 5mm, columns: (1.7fr, 1fr))[

  - æŠ—VGCAæŠ—ä½“é–¢é€£è„³ç‚ã‚„æ©‹æœ¬è„³ç—‡ã®é‘‘åˆ¥ãŒç‰¹ã«é›£ã—ã„
    - è¾ºç¸ç³»ã«ç‚ç—‡ãŒã‚ã‚‹ç‚ºã€è¨˜ååŠ›ä½ä¸‹ãŒå¼·ã„
  - ç™ºç†±ã‚„ä½Naã§æ‹¾ã„ã€é€ å½±MRIã§ #lb ç•°å¸¸ã‚’æ¢ã™
  - ã¨ã¯è¨€ãˆã€é›£ã—ã‘ã‚Œã°è¨ºæ–­çš„æ²»ç™‚ã¨ #lb ã—ã¦PSLãƒ‘ãƒ«ã‚¹ã¯è€ƒæ…®ã—ã¦è‰¯ã„    
#align(right)[
   #text(size: 12pt)[
BRAIN and NERVE 62(4)ï¼š339-345, 2010
]]
  ][

    #image("figures/rpd_etiology.jpeg", height: 80%)

      #align(center)[
    #text(size: 14pt)[
  Nat Rev Neurol. 2022;18(6):363-376.
    ]
  ]

  ]

]

#polylux-slide[
  == ç—…ç†è§£å‰–


#side-by-side(gutter: 1mm, columns: (1fr, 1fr))[
#figure(image("figures/cjd_ncnp_hp.jpeg", width: 60%))
  
  
  #align(center)[
    #text(size: 14pt)[
  å›½ç«‹ç²¾ç¥ãƒ»ç¥çµŒåŒ»ç™‚ç ”ç©¶ã‚»ãƒ³ã‚¿ãƒ¼
  ]
  ]

  #align(right)[
   #text(size: 12pt)[
    https://brain-bank.ncnp.go.jp/
   ]
  ] 

][
  #figure(image("figures/cjd_mihara_hp.jpeg", width: 60%))

  #align(center)[
    #text(size: 14pt)[
    å…¬ç›Šè²¡å›£æ³•äºº è„³è¡€ç®¡ç ”ç©¶æ‰€ ç¾åŸè¨˜å¿µç—…é™¢
  ]
  ]


  #align(right)[
   #text(size: 12pt)[
    https://mihara-ibbv.jp/hp/brain-bank/]
  ] 
]
  - å½“é™¢ã ã¨ç—…ç†è§£å‰–ã¯ä¸å¯èƒ½
  - ç—…ç†è§£å‰–ã‚ã¨ã¯éºæ—ã‚‚ç›´æ¥è§¦ã‚Œã‚‰ã‚Œãªã„äº‹ã«æ³¨æ„
    - äºŒé‡ã®è¢‹ã«å…¥ã‚Œã¦ãŠè¿”ã—ã•ã‚Œã‚‹
  
]

#polylux-slide[
  == Take home message

  - æ€¥é€Ÿé€²è¡Œã®èªçŸ¥ç—‡ã§CJDã‚’ç–‘ã†
  - å…ˆãšã¯ã€é ­éƒ¨MRIã€è„³æ³¢ã€é«„æ¶²æ¤œæŸ»ã§éä¾µè¥²çš„ã«
    - é«„æ¶²æ¤œæŸ»ã®å¤–æ³¨ã¯ç¥çµŒå†…ç§‘ã«ç›¸è«‡
  - ç—…ç†è§£å‰–ã‚’è¡Œã†æ™‚ã‚‚Faã‚„ç—…é™¢ã¨ã®ç›¸è«‡ãŒå¿…è¦
  
]
